A patient originally diagnosed with uterine endometrioid adenocarcinoma had additional clinically relevant PIK3CA and TP53 mutations that further characterize this patient as having pleomorphic rhabdomyosarcoma (Pinto et al., 2018). This evidence concerns the gene PIK3CA and endometrioid adenocarcinoma.